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Background/aim: Gastric cancer (GC) is one of the major causes of cancer mortality worldwide. As a novel type of endogenous
noncoding RNAs, circular RNAs (circRNAs) are formed by a covalent link between 5’ and 3’ ends. They are very stable and abundant
in eukaryotes. As there were no reported studies on the expression profiles of circular RNA ITCH (cir-ITCH) and circHIPK3 in GC, in
the current study, we aimed to delineate the expression profiles and clinicopathological relevance of these two circRNAs in GC tissues
compared to their paired adjacent noncancerous tissues.
Materials and methods: Quantitative real-time polymerase chain reaction was performed to evaluate cir_ITCH and circHIPK3
expression in 30 paired gastric cancer tissues. The clinicopathological relevance of these two circular RNAs’ expression levels with
gastric cancer was further examined.
Results: Our results showed that the expression of cir_ITCH and circHIPK3 were significantly downregulated in GC tumoral tissues
compared with their paired adjacent nonneoplastic counterparts. Further analyses showed that cir_ITCH and circHIPK3 expression
levels were related with numerous clinicopathological features of tumoral tissues.
Conclusion: Cir_ITCH and circHIPK3 may have imperative roles in GC and serve in the future as potential prognostic biomarkers in GC.
Key words: Gastric cancer, circular RNAs, cir_ITCH, circHIPK3, gene expression

1. Introduction
Gastric cancer (GC) is one of the unresolved causes of
cancer mortality worldwide with a high rate of incidence
and death (1,2). It is the second and fourth most common
cancer leading to a high death rate in men and women,
respectively (3,4). Lack of reliable diagnostic methods
in early stages of GC denies the majority of patients an
effective treatment (3,5). Accordingly, to overcome these
problems, it is critical to find novel biomarkers to improve
the chance to diagnose GC in its early stages.
As a novel type of endogenous noncoding RNAs,
circular RNAs (circRNAs) are formed by a covalent link
between 5’ and 3’ ends (6–8). They are very stable and
abundant in eukaryotes (9–11). Recent reports show
that circRNAs can function as microRNA sponges,
regulate gene expression, linear RNA transcription and
protein production (7). Association between circRNAs
and several diseases like atherosclerotic vascular disease
(12), Alzheimer (13), and various cancer types (14) has

been documented and could represent these molecules as
attractive novel biomarkers.
cir-ITCH is a circular RNA which is derived from
Itchy E3 ubiquitin protein ligase (ITCH) gene (10,15).
Deregulation of cir-ITCH has been recently reported
in esophageal squamous cell carcinoma (ESCC) (16),
colorectal cancer (17), and lung cancer. Further functional
studies showed that cir-ITCH can act as microRNA sponge
thus increasing the level of parental gene, ITCH (15).
In 2016, by characterizing circRNA, transcripts using
RNA-sequencing (RNA-seq) from six normal tissues
(brain, colon, heart, liver, lung, and stomach) and seven
cancerous tissues including gastric cancer, Zheng et al.
introduced an abundant circRNA derived from Exon2
of the HIPK3 gene, termed circHIPK3. Their functional
assays revealed that circHIPK3 may function to modulate
the growth of human cells (18).
As there were no reported studies on the expression
profiles of these two circular RNAs in gastric cancer, in
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the current study, we aimed to delineate the expression
profiles of cir-ITCH and circHIPK3 in gastric cancer tissues
compared to their paired adjacent noncancerous tissues.
Then, the clinicopathological relevance of these two
circular RNAs with gastric cancer was further examined.
2. Materials and methods
2.1. Clinical specimens
A total of 30 pairs of gastric cancer and matched adjacent
nontumoral tissues were obtained from patients with
gastric cancer. The specimens were collected by the Iran
National Tumor Bank, which is funded by the Cancer
Institute of Tehran University, for Cancer Research (19–
21). There, the tissues are immediately snap-frozen in
the liquid nitrogen. Informed written consent was taken
from the patients by Iran National Tumor Bank. The study
protocol was approved by the Ethics Committee of Isfahan
University of Medical Sciences and was in accordance with
the Helsinki Declaration. The clinical staging of the tumor
samples was based on the seventh edition of the American
Joint Committee on Cancer classification (AJCC) cancer
staging manual for stomach (22).
2.2. Total RNA extraction and complementary DNA
(cDNA) synthesis
TRIzol® reagent (Invitrogen, California, USA) was used to
extract total RNA from powdered gastric cancer tissues,
following the manufacturer’s instructions. One percent
agarose gel electrophoresis was used to assess the quality
of the RNA. Purity and quantity of the total RNA were
determined with Nanodrop instrument (Nanolytik,
Düsseldorf, Germany). DNase treatment was performed
by using DNase set (Fermentas, Vilnius, Lithuania) for
eliminating genomic DNA. cDNA was synthesized by
using PrimeScriptTM RT reagent Kit (TaKaRa, Kusatsu,
Shiga, Japan) according to manufacturer’s protocol.
2.3. Quantitative real-time PCR and DNA sequencing
Applying the relative quantitative real-time RT-PCR,
the expression levels of cir_ITCH and circHIPK3 were

assessed compared to GUSB (β-Glucuronidase) as an
internal control (23). Divergent primers, rather than
convergent primers, were designed with GeneRunner
software, version 4.0 to amplify the circular RNAs. Basic
local alignment search tool (BLAST) (http://blast.ncbi.
nlm.nih.gov/Blast.cgi) was used for confirmation of unity
attachment of divergent primers to genome. A set of
convergent primers in an opposite direction were designed
to amplify only the linear forms. The sequences of primers
are listed in Table 1. RealQ Plus 2x Master Mix, green (high
ROX) (AMPLIQON, Odense M, Denmark) was applied in
an Applied Biosystems StepOnePlus™ instrument for PCR
amplification. The amplification conditions consisted of
an initial denaturation at 95 °C for 2 min, then 30 cycles
of denaturation at 95 °C for 30 s, annealing at 55.9 °C for
cir_ITCH and circHIPK3 and at 60 °C for GUSB genes for
60 s, and the extension step for 30 s at 72 °C. Furthermore,
the PCR products of some samples were sequenced with
an Applied Biosystems 3730XL sequencer (Macrogen,
Seoul, South Korea) to verify the specific amplification of
circular RNAs.
2.4. Statistical gene expression analysis
The ΔCt method was applied to relatively quantify the
levels of gene expressions. All experiments were performed
at least three times and expressed as means ± standard
error of mean (SEM). To check the normal distribution of
samples, Kolmogorov–Smirnov test was applied. Student’s
t-test, analysis of variance (ANOVA), and chi-square
tests were performed to examine statistical significances.
Data were analyzed by SPSS software, version 16.0 (SPSS,
Chicago, IL, USA) and P-values less than 0.05 were
considered statistically significant.
3. Results
3.1. PCR optimization of the cir_ITCH and circHIPK3
We designed two sets of primer pairs: a divergent primer
set for only amplification of the circular form and a
convergent one to amplify the linear form. We utilized

Table1.The sequences of primers used in the current study.
Name
Divergent
primers

Convergent
primers
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Sequence (5’--> 3’)
hcircITCH-F1

GTCCGGAACTATGAACAATG

hcircITCH-R1

CTCTGTTGGCTCTTTGTCAC

hcircHIPK3-F1

TATGTTGGTGGATCCTGTTC

hcirc HIPK3-R1

AACTGCTTGGCTCTACTTTG

hlinITCH-F1

GGTTCACCATCTGCCACTTC

hlinITCH-R1

AGGGAGCTTGAGTTACAGGATT

hlin HIPK3-F1

GAAAGAAACTATCCACGGAC

hlin HIPK3-R1

TATGACCTTTGTAGCACCTG

Ta for PCR (°C)

Amplicon size

55.9

207 bp

55.9

213 bp

60.7

169 bp

54.4

177 bp
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the cDNA and DNA of a human lung adenocarcinoma
epithelial cell line (A540) for PCR optimization. As
expected, no amplification was seen with divergent primers
on DNA template, whereas we could detect the expected
bands corresponding to circular forms of RNAs (Figure 1).
Products giving a band were sequenced by conventional
Sanger capillary methods and compared to the reference
sequence. Sanger sequencing of the RT-PCR products of
cir_ITCH and circHIPK3 showed that convergent primers
could specifically amplify the circular forms of RNAs (data
not shown).
3.2. cir_ITCH and circHIPK3 expression levels were significantly downregulated in GC tumoral tissues and were
significantly correlated with various clinicopathological
parameters
The results of real-time qRT-PCR experiments showed
that expression of both cir_ITCH and circHIPK3 were
significantly downregulated (P = 0.015 and P = 0.046,
respectively) in GC tumoral tissues compared with their
paired adjacent nontumoral tissues (Figure 2). Analyzing

Figure 1. Identification of circHIPK3 and cir_ITCH in a human
lung adenocarcinoma epithelial cell line (A540). A) RT-PCR
products with divergent and convergent primers of circHIPK3
verified that specificity of designed primers. B) Specific divergent
primers of cir_ITCH could amplify a 207 bp PCR product using a
cDNA as a PCR template but not a genomic DNA (gDNA).

melting curves showed single peaks with neither primer
dimers nor nonspecific amplification, further confirming
the specificity of cir_ITCH and circHIPK3 amplifications.
Further analyses showed that circHIPK3 expression
was related with numerous clinicopathological features of
tumoral tissues. As shown in Table 2, circHIPK3 expression
level was significantly associated with age (P = 0.002) and M
classification (P = 0.045). GC patients were further classified
into two groups based on the median value of circHIPK3
expression in tumoral tissues. circHIPK3 expression levels
stratified based on median value showed a significant
association with age (P = 0.01) (Table 3). Same analyses
on cir_ITCH showed a significant correlation between
circRNA expression levels and age (P = 0.0005) and tumor
grades (P = 0.02) (Tables 4 and 5). We furthermore tested

Figure 2. Relative expression of circHIPK3 and cir_ITCH in
tumoral and nontumoral gastric tissue samples. A higher ΔCt
value shows higher relative expression levels. Error bars stand for
standard error of mean (SEM). A) circHIPK3, B) cir_ITCH.
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Table 2. The relationship between circHIPK3 expression level (based on mean ± SEM gene
expression level) in GC tissues with clinicopathological parameters.
Numbers
(#30)(%)

circHIPK3
(mean ± SEM*)

Gender
Male
Female

17(56.67)
13(44.33)

0.29 ± 0.66
0.37 ± 0.46

0.25

Age (years)
≥70
<70

15(50.00)
15(50.00)

1.93 ± 0.44
−1.28 ± 0.55

0.002**

Depth of invasion
T2
T3-T4

1(3.33.00)
29(96.67)

−3.21 ±
0.45 ± 0.57

0.14

N classification
NX-N0
N1
N2-N3

6(20.00)
11(36.67)
13(43.33)

−1.01 ± 0.81
1.52 ± 0.44
−0.07 ± 0.53

M classification
MX
M0
M1

5(16.67)
19(63.33)
6(20.00)

−0.47 ± 0.23
1.31 ± 0.54
−1.89 ± 0.66

TNM stage
I-II
III
IV

16(53.33)
8(26.67)
6(20.00)

0.86 ± 0.56
0.92 ± 0.44
−1.89 ± 0.66

Perineural invasion
Negative
Positive

12(40.00)
18(60.00)

0.08 ± 0.66
0.57 ± 0.51

0.28

Lymphatic invasion
Negative
Positive

6(20.00)
24(80.00)

0.91 ± 0.53
0.24 ± 0.46

0.20

Tumor size (cm)
≥5
<5

25(83.33)
5(16.67)

0.23 ± 0.57
0.79 ± 0.64

0.40

Tumor grades
I
II
III

9(30.00)
8(26.67)
13(43.33)

−0.84 ± 0.67
0.98 ± 0.61
0.73 ± 0.48

Tumor types
Diffuse
Intestinal

14(46.67)
16(53.33)

0.78 ± 0.49
−0.07 ± 0.64

Characteristics

P-value

0.16

0.045**
(M0 vs. M1)

0.16

0.25

0.38

* A higher ΔCt value indicates higher expression.
** Statistically significant.

if there is any correlation between gene expression levels
and the anatomical location of tumors within the stomach.
Although the stomach is anatomically divided into four
regions, i.e. the cardia, fundus, body, and pylorus, the two
main regions in our patient cohort were the cardia and the
main body. Therefore, we compared the gene expressions
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between these two groups (body vs. cardia) and found no
statistically significant difference in gene expressions of the
two examined circular RNAs between tumors in the main
body of the stomach and the ones in cardia (1.06 ± 1.03 vs.
−1.54 ± 1.67 for cir_ITCH (P = 0.20) and 1.14 ± 0.62 vs.
−0.57 ± 1.18 for circHIPK3 (P = 0.22)).
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Table 3. The relationship between circHIPK3 expression level (as divided into two groups based on the median of
ΔCt) in GC tissues with clinicopathological parameters
Characteristic

Number (#30)

circHIPK3 expression
Low (#15)

High (#15)

P-value

Gender
Male
Female

17
13

9
6

8
7

0.50

Age (years)
≥70
<70

15
15

4
11

11
4

0.01**

Depth of invasion
T2
T3-T4

1
29

1
14

15

0.50

N classification
NX-N0
N1
N2-N3

6
11
13

3
4
8

3
7
5

M classification
MX
M0
M1

5
19
6

4
7
4

1
12
2

TNM stage
I-II
III
IV

16
8
6

7
4
4

9
4
2

Perineural invasion
Negative
Positive

12
18

6
9

6
9

0.50

Lymphatic invasion
Negative
Positive

6
24

2
13

4
11

0.32

Tumor size (cm)
≥5
<5

25
5

12
3

13
2

0.50

Tumor grades
I
II
III

9
8
13

6
4
5

3
4
8

Tumor types
Diffuse
Intestinal

14
16

6
9

8
7

0.23

0.09
(M0 vs. M1)

0.31

0.21

0.35

* A higher ΔCt value indicates higher expression.
** Statistically significant.

4. Discussion
In the current study, we explored the expression levels
of circHIPK3 and cir_ITCH in gastric cancer tissues
compared to their paired adjacent noncancerous tissues as
well as their clinicopathological significance.

Our results showed a significant underexpression of
circHIPK3 in GC tumoral tissues. Using RNA sequencing
(RNA-seq), Zheng et al. (18) characterized an abundant
circular RNA derived from the HIPK3 gene, termed
circHIPK3. They reported the significant overexpression
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Table 4. The relationship between cir_ITCH expression level (based on mean ± SEM gene expression level) in
GC tissues with clinicopathological parameters
Characteristics

Numbers (#30)(%)

cir_ITCH (mean±SEM*)

P-value

Gender
Male
Female

16(53.33)
14(46.66)

0.31 ± 0.93
0.23 ± 0.75

0.42

Age (years)
≥70
<70

14(46.66)
16(53.33)

2.66 ± 0.76
−2.11 ± 0.69

0.0005**

Depth of invasion
T2
T3-T4

1(3.33)
29(96.67)

0.45 ±
0.27 ± 0.85

0.50

N classification
NX-N0
N1
N2-N3

6(20.00)
11(36.67)
13(43.33)

−1.18 ± 1.25
0.89 ± 0.87
0.42 ± 0.61

M classification
MX
M0
M1

5(16.67)
19(63.33)
6(20.00)

−2.24 ± 0.33
1.76 ± 0.63
−1.62 ± 1.34

TNM stage
I-II
III
IV

16(53.33)
8(26.67)
6(20.00)

1.19 ± 0.68
0.41 ± 0.60
−2.35 ± 1.35

Perineural invasion
Negative
Positive

12(40.00)
18(60.00)

Lymphatic invasion
Negative
Positive

6(20.00)
24(80.00)

3.28 ± 1.60
−0.04 ± 0.89

0.08

Tumor size (cm)
≥5
<5

25(83.33)
5(16.67)

−0.02 ± 0.89
1.72 ± 0.49

0.19

Tumor grades
I
II
III

9(30.00)
8(26.67)
13(43.33)

−2.36 ± 0.84
−0.77 ± 0.61
2.74 ± 0.77

Tumor types
Diffuse
Intestinal

14(46.66)
16(46.66)

1.68 ± 0.82
−0.96 ± 0.82

−0.34 ± 0.96
0.68 ± 0.77

0.45

0.16
(M0 vs. M1)

0.23

0.44

0.02**

0.06

* A higher ΔCt value indicates higher expression.
** Statistically significant.

of circHIPK3 in liver cancer compared with their matched
normal tissues. In 2017, Li et al. (24) measured the relative
expression of circHIPK3 in 44 pairs of bladder cancer and
normal bladder tissues. Consistent with their RNA-seq
results, they observed a significant decrease of circHIPK3
levels in 79.5% of bladder tumoral tissues compared to
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their normal counterparts. Overexpression of circHIPK3
in bladder cancer cell lines could suppress migration,
invasion, and angiogenesis in vitro and inhibit bladder
cancer growth and metastasis in vivo. Their findings
support the tumor-suppressive activity of circHIPK3 in
bladder cancer. In agreement with the results of expression
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Table 5. The relationship between cir_ITCH expression level (as divided into two groups based on the median of
ΔCt) in GC tissues with clinicopathological parameters.
Characteristic

Number (#30)(%)

cir_ITCH expression
Low (#15)

High (#15)

P-value

Gender
Male
Female

16
14

7
8

9
6

0.36

Age (years)
≥70
<70

14
16

2
13

12
3

0.0005**

Depth of invasion
T2
T3-T4

1
29

1
14

0
15

0.50

6
11
13

5
5
5

1
6
8

5
19
6

5
7
3

0
12
3

16
8
6

7
4
4

9
4
2

Perineural invasion
Negative
Positive

12
18

5
10

7
8

0.35

Lymphatic invasion
Negative
Positive

6
24

2
13

4
11

0.34

Tumor size (cm)
≥5
<5

25
5

12
3

13
2

0.50

Tumor grades
I
II
III

9
8
13

7
4
4

2
4
9

Tumor types
Diffuse
Intestinal

14
16

5
10

9
6

N classification
NX-N0
N1
N2-N3
M classification
MX
M0
M1
TNM stage
I-II
III
IV

0.08

0.28
(M0 vs. M1)

0.31

0.04**

0.13

* A higher ΔCt value indicates higher expression.
** Statistically significant.

of this circular RNA in bladder cancer (24), we also
observed the relative downregulation of circHIPK3 in
gastric cancer tumoral tissues. The discrepancy between Li
et al. (24) and our results vs. findings of Zheng et al. (18)
on liver cancer may be ascribed to the potential tissuespecific expression and function of circHIPK3.

We furthermore analyzed the relative expression
of cir_ITCH in GC and found that it was significantly
underexpressed in tumoral tissues compared to the
nontumoral adjacent tissues. The association between
cir_ITCH and cancer was firstly described in a study
on esophageal squamous cell carcinoma conducted by
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Li et al. (16). cir_ITCH was highly and significantly
expressed in around 70.61% of tumoral tissues compared
to their paired nontumoral tissues (16). Evaluation of
cir_ITCH expression in colorectal cancer (17) showed its
underexpression in 75.6% of cancerous tissues compared
with the adjacent noncancerous tissues. In 2016, Wan et
al. (15) evaluated the expression levels of cir_ITCH in a
cohort of lung cancer compared to their paired adjacent
normal tissues. Compared to non-tumoral lung tissues,
cir_ITCH showed a significantly lower expression in
73.08% of tumoral tissues (15). Taken together, our result
on gastric cancer is consistent with those of previous
reports on ESCC (16), colorectal cancer (17), and lung
cancer (15).
In 2017, Li et al. (24) reported a negative correlation
of circHIPK3 expression levels with bladder cancer grade,
invasion, stage and the lymph nodes metastasis. In the same
vein, we also observed that those patients with metastasis
had a significant lower expression levels for this circular
RNA. Gastric cancer patients with higher TNM stage or
positive lymphatic invasion had lower levels of circHIPK3,
although these correlations were not significant.

Furthermore, we found that the cir_ITCH expression
level was significantly associated with age, metastasis, and
cancer grades. Consistently, Wan et al. (15) reported a
significant association between age and expression levels
of this circular RNA in a cohort of lung cancer tissues.
5. Conclusions
In summary, our results showed that the expression of cir_
ITCH and circHIPK3 were significantly down regulated in
GC tumoral tissues compared with their paired adjacent
non-neoplastic counterparts. Further investigation of
these preliminary results is needed to elucidate the precise
functional roles of these two circular RNAs in gastric
cancer pathogenesis. cir_ITCH and circHIPK3 may serve
in future as potential prognostic biomarkers in cancer.
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